Immunizations in chronic liver disease: What should be done and what is the evidence

Current Gastroenterology Reports

Volumn 15, Issue 1, 2013, Pages

  Leise, Michael D ^a   Talwalkar, Jayant A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic liver disease; Cirrhosis; Immunization; Vaccination

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DRUG MEGADOSE; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; INFLUENZA VACCINATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORTALITY; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SEROLOGY; VARICELLA ZOSTER VIRUS; WART VIRUS; CHRONIC DISEASE; EVIDENCE BASED MEDICINE; IMMUNOLOGY; LIVER DISEASE; REVIEW;

CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; LIVER DISEASES; PNEUMOCOCCAL VACCINES;

EID: 84871124169     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0300-6     Document Type: Article

References (47)

1. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246-56. 1256 e1241-1245. This meta-analysis highlights the importance of infections in patients with cirrhosis whereby 30% die at 30 days, and another 30% die at 12 months.
2. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med. 2000;160:113-5. (Pubitemid 30040980)
3. Song JY, Cheong HJ, Ha SH, Hwang IS, Kee SY, Jeong HW, Lee CG, Kim WJ. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clinic Virolog. 2007;39:159-63. The influenza vaccination prevented hepatic decompensation in this study when compared to patients who did not undergo immunization. (Pubitemid 46907732)
4. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286-90. (Pubitemid 28065254)
5. Krogsgaard K, Wantzin P, Mathiesen L, Ring-Larsen H. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme. Scand J Gastroenterol. 1991;26:275-80.
6. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 1993;104:549-55. (Pubitemid 23033429)
7. Kramer JR, Hachem CY, Kanwal F, Mei M, El-Serag HB. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011;53:42-52. The performance of hepatitis A or B vaccinations or detection of protective antibodies in a large U.S. population with hepatitis C, was poor.
8. Recommended adult immunization schedule: United States, 2012. Ann Intern Med. 2012;156:211-217. Current U.S. Guidelines on Immunizations.
9. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-2.
10. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-74.
11. Bond TC, Spaulding AC, Krisher J, McClellan W. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis Official J National Kidney Foundation. 2012.
12. Heymann AD, Shapiro Y, Chodick G, Shalev V, Kokia E, Kramer E, Shemer J. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care. 2004;27:2581-4. (Pubitemid 39441454)
13. Gurfinkel EP, Leon dela Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Hear J. 2004;25:25-31. (Pubitemid 38055589)
14. Gaeta GB, Stornaiuolo G, Precone DF, Amendola A, Zanetti AR. Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis. Vaccine. 2002;20 Suppl 5:B33-5. (Pubitemid 35435395)
15. Gaeta GB, Pariani E, Amendola A, Brancaccio G, Cuomo G, Stornaiuolo G, Zappa A, Zanetti A. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine. 2009;27:3373-5.
16. Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant. 2004;4:1805-9. (Pubitemid 39434441)
17. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transplant. 2001;7:311-3. (Pubitemid 32331534)
18. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus AD. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000;61:85-93. (Pubitemid 30191231)
19. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J. 1985;290:505-8. (Pubitemid 15075948)
20. McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis. 2000;181:757-60. (Pubitemid 30131855)
21. Younossi ZM, Stepanova M. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. Hepatology. 2011;54:1167-78.
22. Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol. 1990;85:1590-2.
23. Van Thiel DH, El-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci. 1992;37:1245-9.
24. Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, Weesner RE, Morgan DD. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci. 1988;33:263-9.
25. Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transplant Surg. 1998;4:128-32.
26. Horlander JC, Boyle N, Manam R, Schenk M, Herring S, Kwo PY, Lumeng L, Chalasani N. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci. 1999;318:304-7. (Pubitemid 30349663)
27. Bonazzi PR, Bacchella T, Freitas AC, Osaki KT, Lopes MH, Freire MP, Machado MC, Abdala E. Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. Brazil J Infect. 2008;12:306-9. Dialysis or double dose Hepatitis B vaccination is more effective than standard dose Hepatitis B vaccinations in patients awaiting liver transplantation.
28. Idilman R, Colantoni A, De Maria N, Ustun C, Sam R, Ing TS, Akan H, Koc H, Van Thiel DH. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals. Hepato-Gastroenterology. 2003;50:217-21. (Pubitemid 36182971)
29. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine. 2005;23:2902-8. (Pubitemid 40386492)
30. Dominguez M, Barcena R, Garcia M, Lopez-Sanroman A, Nuno J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000;6:440-2. (Pubitemid 30489116)
31. Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2001;7:314-20. (Pubitemid 32331535)
32. Engler SH, Sauer PW, Golling M, Klar EA, Benz C, Stremmel W, Kallinowski B. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol. 2001;13:363-7. (Pubitemid 32319900)
33. De Maria N, Idilman R, Colantoni A, Van Thiel DH. Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis. J Viral Hepat. 2001;8:372-6. (Pubitemid 34205891)
34. Idilman R, De MN, Colantoni A, Nadir A, Van Thiel DH. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol. 2002;97:435-9. (Pubitemid 34160772)
35. Macedo G, Maia JC, Gomes A, Teixeira A, Ribeiro T. Efficacy of a reinforced protocol of HBV vaccination in cirrhotic patients waiting for orthotopic liver transplantation. Transplant Proc. 2000;32:2641. (Pubitemid 32008177)
36. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol. 1995;90:201-5.
37. Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology. 2001;34:28-31. (Pubitemid 32591479)
38. Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, Henderson JM, Carey WD. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol. 1999;94:1601-4. (Pubitemid 29260452)
39. Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus? J Gastroenterol Hepatol. 2009;24:238-42.
40. Oliveira LC, Comacio SM, Santos JF. Seroprevalence of hepatitis A immunity among brazilian adult patients with liver cirrhosis: is HAV vaccination necessary? The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases. 2011;15:268-71.
41. Song HJ, Kim TH, Song JH, Oh HJ, Ryu KH, Yeom HJ, Kim SE, Jung HK, Shim KN, Jung SA, et al. Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. J Kor Med Sci. 2007;22:218-22.
42. Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol. 2002;97:721-8. (Pubitemid 34245904)
43. Chapko MK, Yee HS, Monto A, Dominitz JA. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C. Vaccine. 2010;28:1726-31.
44. Smallwood GA, Coloura CT, Martinez E, Stieber AC, Heffron TG. Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine? Transplant Proc. 2002;34:3289-90. (Pubitemid 35463321)
45. Knoll A, Hottentrager B, Kainz J, Bretschneider B, Jilg W. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults. Vaccine. 2000;18:2029-32. (Pubitemid 30114347)
46. Kramer ES, Hofmann C, Smith PG, Shiffman ML, Sterling RK. Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis. Dig Dis Sci. 2009;54:2016-25.
47. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305:160-6.